Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Clinical & Translational Immunology|December 16, 2014
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyMichael P Pender, Scott R Burrows
Clinical & Translational Immunology|July 28, 2017
Erratum: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosisMichael P Pender, Peter A Csurhes, Jacqueline M Burrows, et al.
Clinical & Translational Immunology|February 16, 2017
Defective T-cell control of Epstein-Barr virus infection in multiple sclerosisMichael P Pender, Peter A Csurhes, Jacqueline M Burrows, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2014
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosisMichael P Pender, Peter A Csurhes, Casey Mm Pfluger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 5, 2014
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosisMichael P Pender, Peter A Csurhes, Corey Smith, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|November 16, 2010
The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosisMichael P Pender
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 1, 2004
The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?Michael P Pender
Pageof 13